Osteoporosis News

Approximately 1.26 million hip fractures occurred in the U.S. in 1990, and researchers estimate the number may jump to 2.6 million by 2025 and 4.5 million by 2050.1,2 The percentage increase is expected to be ...

As drugs stocks trended lower Monday, Amgen Inc. broke from the pack, gaining on positive data releases on its osteoporosis-drug candidate denosumab.

The Health Secretary must overturn 'farcical' rules that deny thousands of women medicine for thinning bones, campaigners say.

Amgen Inc. took another step toward FDA approval of its Denosumab treatment for bone loss Friday, saying its latest study shows the therapy reduced the incidence of new fractures in women with postmenopausal ...

In every recession there's usually one bright spot for marketers: drugs. As consumers skimp on food, fuel and clothes, the business of health often benefits from "nondiscretionary" spending.

NEW YORK - In an animal study of osteoporosis, researchers have shown that low-dose aspirin can decrease the activity of cells that breakdown bone, while increasing the activity of cell that ...

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA , Vol.

Calculating a woman's bone mineral density appears to shed light on her risk for breast cancer .

Shares of Amgen Inc. rallied Monday, propelled by positive trial data on osteoporosis drug candidate denosumab, a product that many investors are hoping can jump-start the biotech giant's top line.

Distal radius fracture is an early sign of general osteoporosis: bone mass measurements in a population-based study.

Colles' fracture of the wrist as an indicator of underlying osteoporosis in postmenopausal women: a prospective study of bone mineral density and bone turnover rate.

But the results topped Wall Street forecasts after excluding the charges, and the stock reached its highest point in more than a year Monday, buoyed by positive study results on the company's next possible ...

Even if you don't think you do, you already know plenty about commodities. Want us to prove it? No problem.

New questions have emerged about whether long-term use of bone-building drugs for osteoporosis may actually lead to weaker bones in a small number of people who use them.

Association between Colles' fracture and low bone mass: age-based differences in postmenopausal women.